Erweiterte Suche

Matthew Guy Farrell has worked as a Director at Delta Technical Services Ltd.
since 2009.

Mr. Matthew P.
Farrell, CFA, is an Investment Director at London & Capital Asset Management Ltd.
He provides a conduit between his investment colleagues and some of the firm’s largest clients.
He has over 15 years of experience in financial markets.
Prior to London & Capital, Mr. Farrell was a Portfolio Manager and Currency Strategist for several institutional asset management houses, managing both developed and emerging market currency strategies in currency overlays, funds and structured products.
Mr. Farrell has a BA in Politics with Economics from Loughborough University and is a CFA Charterholder.

Matthew F.
Farrell is a Senior Research Analyst at Piper Sandler & Co. (Broker).
He previously worked as an Analyst at William Blair & Co. LLC from 2014 to 2015 and as a Principal at Kappa Delta Sorority, Inc. in 2014.
Mr. Farrell completed his undergraduate degree at Indiana University in 2014.

Herr Matthew T. Farrell ist ein unabhängiges Mitglied des Verwaltungsrats bei Trinseo SA und ein Chairman, President & Chief Executive Officer bei Church & Dwight Co. Er ist Mitglied des Board of Directors bei Trinseo SA und QGN Participaes SA. Herr Farrell war zuvor als unabhängiger Direktor bei Lydall, Inc. beschäftigt, als Chief Financial Officer bei Alpharma, Inc. als Chief Financial Officer & Executive Vice President bei Alpharma LLC, als Vice President-Investor Relations & Communications bei Ingersoll Rand, Inc, ein VP-Investor Relations & Communications bei Ingersoll-Rand Plc, ein Director-Corporate Audit bei AlliedSignal, Inc. ein Chief Financial Officer-Specialty Chemicals bei Honeywell International LLC, ein Audit Partner bei KPMG Peat Marwick LLP und ein VP-Investor Relations & Communications bei Gardner Denver, Inc. Seinen Bachelor-Abschluss erhielt er am Manhattan College.

Leigh Bernard Farrell is currently an Independent Non-Executive Director at Pro Medicus Ltd.
He is also the Managing Director & Executive Director at Adned Pty Ltd., a Non-Executive Director at Ena Respiratory Pty Ltd., a Member at the Australian Institute of Co. Directors, and the Head-Health Security Division at DMTC Ltd.
In the past, Dr. Farrell has worked as the Chief Executive Officer at Gene Shears Pty Ltd., Chairman & Chief Operating Officer at d3 Medicine LLC, Associate Director at GBS Venture Partners Pty Ltd., Director at Cortical Pty Ltd., Research Manager at Johnson & Johnson Research Pty Ltd., Senior Vice President-Commercial at Certara USA, Inc., and Vice President-Business Development at Aviragen Therapeutics, Inc.Dr. Farrell obtained his undergraduate and doctorate degrees from Monash University.